Fabian Kreimendahl

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase <scp>IIIb</scp> randomized, double‐blind, parallel‐group, <scp>GUIDE</scp> study

Knut Schäkel, Kristian Reich, K. Asadullah et al. · Journal of the European Academy of Dermatology and Venereology · 2023 · 86 citations · Full text

Quality of life and costs of spasticity treatment in German stroke patients

Reinhard Rychlik, Fabian Kreimendahl, Nicole Schnur et al. · Health Economics Review · 2016 · 29 citations · Full text

Efficacy and Tolerability of a House Dust Mite Allergoid in Allergic Bronchial Asthma: A Randomized Dose-Ranging Trial

Marek Jutel, Michael Rudert, Fabian Kreimendahl et al. · Immunotherapy · 2018 · 29 citations · Full text

Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study

Dirk Dressler, Reinhard Rychlik, Fabian Kreimendahl et al. · BMJ Open · 2015 · 22 citations · Full text

Effectiveness, safety and quality‐of‐life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non‐interventional, prospective, German multicentre <scp>PERSIST</scp> study

Sascha Gerdes, Matthias Hoffmann, K. Asadullah et al. · Journal of the European Academy of Dermatology and Venereology · 2023 · 15 citations · Full text